Investing.com - Chinook Therapeutics reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Chinook Therapeutics announced earnings per share of $-0.83 on revenue of $2.5M. Analysts polled by Investing.com anticipated EPS of $-0.63 on revenue of $60K.
Chinook Therapeutics shares are down 53.92% from the beginning of the year, still down 5.87% from its 52 week high of $23.86 set on September 9.
Chinook Therapeutics follows other major Healthcare sector earnings this month
Chinook Therapeutics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar